Meramonte, Lorna D.

HRN: 28-88-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CEFTAZIDIME 1GM (VIAL)
04/17/2026
04/24/2026
IV
2g
Q8
CAPMR, Presumptive PTB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines